Skip to main content

Table 3 Expression of PGI, PGII and PGI/II ratio in situ and in serum

From: Pepsinogen I and II expressions in situ and their correlations with serum pesignogen levels in gastric cancer and its precancerous disease

Gastric mucosa

N

In situ PGI (IRS)

In situ PGII (IRS)

In situ PGI/II ratio

Serum PGI (microg/L)

Serum PGI (microg/L)

Serum PGI/II ratio

NOR

30

7.5(5.0,10.0)

8.5(5.8,10.3)

1.0(0.7,1.1)

68.2(47.8,146.8)

6.3(4.1,9.2)

15.3(8.9,20.2)

GS

70

6.0(3.0,9.00

6.0(3.0,9.0)

1.0(0.7,1.4)

72.5(53.5,102.3)

6.4(4.3,13.9)

9.8(7.6,14.3)

GA

54

2.0(1.0,3.0)

2.5(1.0,4.3)

0.8(0.4,1.1)

87.4(56.3,127.1)

10.7(6.6,15.6)

8.6(4.8,12.4)

GC

31

0.0(0.0,0.0)

0.0(0.0,0.0)

0.0(0.0,0.0)

86.6(64.8,139.2)

15.8(7.7,24.9)

6.1(3.7,11.7)

  1. Note: levels of PGI, PGII and PGI/II ratio were represented as median (25%,75%).